MedPath

A randomised controlled trial on prevention of colonization of Staphylococcus aureus in neonates using multiple Bifidobacteria

Not Applicable
Conditions
Prevention of colonization of S. aureus
Registration Number
JPRN-UMIN000033114
Lead Sponsor
Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Neonate whose birth weight is 2000g or more. 2) Infants with a surgical disease (esophageal atresia, diaphragmatic hernia, etc.), long-term enteral nutrition / oral medication administration can not be expected. 3) Neonate who judged to be ineligible by research facility director or research doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Colonization rate of S. aureus in specimens collected in feces, pharynx (nasal culture) up to 4 weeks after birth in each group.
Secondary Outcome Measures
NameTimeMethod
Measurement of the numbers of three strains Bifidobacterium and Staphylococcus aureus in each group in feces collected at 1 week, 2 weeks and 4 weeks after birth. Difference between the age of each group and birth weight reversion Correlation between weight gain rate and each group at week 40 weeks in preterm infants
© Copyright 2025. All Rights Reserved by MedPath